Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:13 pm Purchase | 2025-09-30 | 13G | Avidity Biosciences, Inc. RNA | RA Capital Management, L.P. | 8,641,031 5.900% | 2,340,623 (+37.15%) | Filing History |
| 2025-11-14 12:19 pm Sale | 2025-09-30 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 9,787,912 7.100% | -846,050 (-7.96%) | Filing History |
| 2025-11-14 11:58 am Purchase | 2025-09-30 | 13G | Avidity Biosciences, Inc. RNA | JANUS HENDERSON GROUP PLC JHG | 14,522,915 10.700% | 2,390,807 (+19.71%) | Filing History |
| 2025-11-07 11:13 am Sale | 2025-10-31 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 2,958,712 2.100% | -18,589,271 (-86.27%) | Filing History |
| 2025-11-05 11:26 am Purchase | 2025-09-30 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 21,547,984 15.000% | 5,932,920 (+37.99%) | Filing History |
| 2025-10-30 2:24 pm Purchase | 2025-09-30 | 13G | Avidity Biosciences, Inc. RNA | VANGUARD GROUP INC | 13,219,759 9.570% | 3,992,875 (+43.27%) | Filing History |
| 2025-10-29 9:14 pm Sale | 2025-10-27 | 13D | Avidity Biosciences, Inc. RNA | RTW Investments, LP | 4,686,110 3.100% | -7,393,624 (-61.21%) | Filing History |
| 2025-10-17 6:05 pm Sale | 2025-09-30 | 13G | Avidity Biosciences, Inc. RNA | BlackRock Inc. BLK | 8,631,771 6.400% | -411,208 (-4.55%) | Filing History |
| 2025-08-07 10:34 am Purchase | 2025-07-31 | 13G | Avidity Biosciences, Inc. RNA | JANUS HENDERSON GROUP PLC JHG | 12,132,108 10.100% | 670,475 (+5.85%) | Filing History |
| 2025-05-14 12:15 pm Purchase | 2025-03-31 | 13G | Avidity Biosciences, Inc. RNA | JANUS HENDERSON GROUP PLC JHG | 11,461,633 9.500% | 4,408,623 (+62.51%) | Filing History |
| 2025-05-12 10:44 am Purchase | 2025-03-31 | 13G | Avidity Biosciences, Inc. RNA | WELLINGTON MANAGEMENT GROUP LLP | 9,684,556 8.100% | 2,653,607 (+37.74%) | Filing History |
| 2025-05-12 10:24 am Purchase | 2025-03-31 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 15,615,064 13.000% | 5,210,968 (+50.09%) | Filing History |
| 2025-04-17 09:35 am Purchase | 2025-03-31 | 13G | Avidity Biosciences, Inc. RNA | BlackRock Inc. BLK | 9,042,979 7.500% | 2,546,386 (+39.20%) | Filing History |
| 2025-02-14 11:24 am Purchase | 2024-12-31 | 13G | Avidity Biosciences, Inc. RNA | JANUS HENDERSON GROUP PLC JHG | 7,053,010 5.900% | 7,053,010 (New Position) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | RA Capital Management, L.P. | 6,300,408 5.400% | 1,404,449 (+28.69%) | Filing History |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 10,633,962 9.000% | 977,110 (+10.12%) | Filing History |
| 2024-11-14 09:39 am Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | Avoro Capital Advisors LLC | 9,935,792 8.300% | 9,935,792 (New Position) | Filing History |
| 2024-11-13 4:40 pm Sale | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | Cowen Financial Products LLC | 0 0.000% | -5,629,103 (Position Closed) | Filing History |
| 2024-11-13 4:05 pm Unchanged | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | BRISTOL MYERS SQUIBB CO BMY | 5,075,304 4.300% | 0 (Unchanged) | Filing History |
| 2024-11-12 1:26 pm Unchanged | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | VANGUARD GROUP INC | 9,226,884 7.840% | 0 (Unchanged) | Filing History |